Search
for
Sort by
Research 31–60 of 371
- A systematic review of dermatologic manifestations among adult patients with COVID‐19 diagnosis
- Non‐infective mucocutaneous presentations of human immunodeficiency virus infection
- Correction: RASopathic Skin Eruptions during Vemurafenib Therapy
- Skin, mucosa and nail findings in hospitalized pediatric patients with Coronavirus disease-2019 (COVID-19)
- Cutaneous manifestations of COVID-19
- Severe cutaneous adverse reactions to drugs
- Pustular allergic contact dermatitis caused by fragrances
- COVID-19 infection leading to acute pustular dermatoses
- Semaglutide-Induced Atypical Pustular Drug Eruption: A Case Report
- Etoricoxib
- SDRIFE Induced by Tofacitinib
- Presentation and Management of Cutaneous Manifestations of COVID-19
- 345. Dermatological Manifestations in Patients with COVID-19 Pneumonia in Veracruz, Mexico
- Ichthyosiform Erythroderma, a Multifaceted Syndromic Entity
- Adverse Cutaneous Reactions to Antipsychotics
- Dermatologic manifestations of COVID‐19: a comprehensive systematic review
- Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge
- Dermatological Manifestations in Patients with COVID-19 Pneumonia in Veracruz, Mexico
- TOC
- Skin and hair disorders
- Anticonvulsant-Induced Cutaneous Reactions
- Transient heart failure in an adult with kawasaki disease
- Psychoactive drugs and skin
- KERION MICROSPORICUM WITH HEMATOGENOUS AND ECTOGENOUS MICROSPORIDS
- 603 Degradation of aberrant NETs by DNases is a promising therapeutic strategy for SJS/TEN
- Cutaneous Drug Reaction Case Reports
- Evolution, mechanism of action, and clinical applications of three generations of antihistamines
- Dermatophytosis due to Microsporum nanum infection in a canine
- Cirmcumscribed juvenile pityriasis rubra pilaris in a 5-year-old-girl treated with topical keratolytic and steroid
- Finasteride